"Nucleus Network runs early-stage clinical trials for some of the world’s leading pharmaceutical companies in Melbourne. We are always looking for healthy volunteers from all walks of life. You can make a difference by assisting with the research of new medicines and be reimbursed up to $480 per day for your valuable time."

During the past decade, Nucleus Network conducted 110 clinical trials. In the 10-year time frame, 110 clinical trials started and 12 clinical trials were completed, i.e. on average, 10.9% percent of trials that started reached the finish line to date. In the past 5 years, 59 clinical trials started and 11 clinical trials were completed. i.e. 18.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nucleus Network" #1 sponsor was "Medicines for Malaria Venture" with 6 trials, followed by "BeiGene" with 5 trials sponsored, "Galera Therapeutics, Inc." with 4 trials sponsored, "Syneos Health" with 4 trials sponsored and "Pieris Australia Pty Ltd" with 4 trials sponsored. Other sponsors include 90 different institutions and companies that sponsored additional 92 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nucleus Network" #1 collaborator was "Clinical Network Services (CNS) Pty Ltd" with 7 trials as a collaborator, "Q-Pharm Pty Limited" with 6 trials as a collaborator, "Novotech (Australia) Pty Limited" with 5 trials as a collaborator, "QIMR Berghofer Medical Research Institute" with 5 trials as a collaborator and "Syneos Health" with 3 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Nucleus Network" are "Healthy" (18 trials), "Healthy Volunteers" (17 trials), "Healthy Subjects" (5 trials), "Malaria" (5 trials) and "Alzheimer Disease" (4 trials). Many other conditions were trialed in "Nucleus Network" in a lesser frequency.

Most popular intervention types in "Nucleus Network" are "Drug" (106 trials), "Other" (17 trials), "Biological" (13 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (43 trials), "OZ439" (3 trials), "Placebos" (3 trials), "BGB-A317" (2 trials) and "DSM265" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nucleus Network" are 105 trials for "All" genders, 11 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Nucleus Network". undefined are not yet recruiting, 19 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 84 completed trials in Nucleus Network, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Nucleus Network, 111 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".